Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report)’s stock price dropped 0.6% during mid-day trading on Monday . The company traded as low as $0.7270 and last traded at $0.90. Approximately 253 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 9,053 shares. The stock had previously closed at $0.9055.
Peak Pharmaceuticals Stock Performance
The business’s 50 day simple moving average is $1.56 and its two-hundred day simple moving average is $1.76.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Articles
- Five stocks we like better than Peak Pharmaceuticals
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
